Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

HealthLynked (HLYK) Net Margin (2016 - 2025)

HealthLynked (HLYK) has disclosed Net Margin for 10 consecutive years, with 136.3% as the latest value for Q3 2025.

  • On a quarterly basis, Net Margin rose 14692.0% to 136.3% in Q3 2025 year-over-year; TTM through Sep 2025 was 118.47%, a 3856.0% increase, with the full-year FY2024 number at 203.81%, down 18613.0% from a year prior.
  • Net Margin was 136.3% for Q3 2025 at HealthLynked, down from 73.5% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 101.57% in Q4 2021 to a low of 3965.81% in Q4 2022.
  • A 5-year average of 312.65% and a median of 117.31% in 2024 define the central range for Net Margin.
  • Peak YoY movement for Net Margin: plummeted -406738bps in 2022, then surged 382774bps in 2023.
  • HealthLynked's Net Margin stood at 101.57% in 2021, then crashed by -4004bps to 3965.81% in 2022, then skyrocketed by 97bps to 138.07% in 2023, then plummeted by -44bps to 198.76% in 2024, then surged by 31bps to 136.3% in 2025.
  • Per Business Quant, the three most recent readings for HLYK's Net Margin are 136.3% (Q3 2025), 73.5% (Q2 2025), and 79.74% (Q1 2025).